We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

A Better Way to Personalize Bladder Cancer Treatments

News   Aug 18, 2015

 
A Better Way to Personalize Bladder Cancer Treatments
 
 
Advertisement
 

RELATED ARTICLES

Team Identifies Potential Pitfall in Emerging Treatment for Cancer and Inflammation

News

Whilst studying an emerging drug target in cancer and inflammation, researchers discovered the unintended activation of a protein called ERK5, this activation was due to the binding location of the inhibitors. ERK5 inhibitors that bound to the kinase domain of the protein led to the protein being shuttled to the cell nucleus and activated. Blocking ERK5 has therapeutic potential, but activating it could have undesirable consequences in terms of stimulated unwanted cell growth.

READ MORE

A New Approach to Understanding the Biology of Wound Healing

News

Researchers use discarded wound dressings as a novel and non-invasive way to study the mechanisms that promote healing.

READ MORE

Collaborations Aim to Meet Unmet Clinical Needs in Biomarker Discovery and Characterization

News

Thermo Fisher Scientific announced agreements with AstraZeneca and the University of Nebraska Medical Center that will showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE